Edition:
United States

Diversified Chemicals

Page 1

R&I affirms Sumitomo Chemical's rating at "A" and says stable outlook-R&I

Friday, 22 Sep 2017 05:13am EDT

Sept 22 (Reuters) - Sumitomo Chemical Co Ltd <4005.T>:* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A"-R&I.* Rating outlook stable-R&I .

Zhejiang Jiangshan Chemical's shares to resume trade on Sept 18

Sunday, 17 Sep 2017 09:54am EDT

Sept 17 (Reuters) - Zhejiang Jiangshan Chemical Co Ltd <002061.SZ>:Says it gets securities regulator's approval for assets acquisition.Says its shares to resume trade on Sept 18.

Incitec Pivot not appointed preferred tenderer in Queensland government's pilot gas tender​

Monday, 4 Sep 2017 08:54pm EDT

Sept 5 (Reuters) - Incitec Pivot Ltd :IPL not appointed preferred gas tenderer.‍IPL not appointed preferred tenderer in queensland government's pilot gas tender​.

Shandong Hualu Hengsheng Chemical's H1 net profit up 11.3 pct y/y

Thursday, 17 Aug 2017 03:48am EDT

Aug 17 (Reuters) - Shandong Hualu Hengsheng Chemical Co Ltd <600426.SS>:Says H1 net profit up 11.3 percent y/y at 545.5 million yuan ($81.85 million).

Hawkins reports Q1 earnings per share $0.55

Tuesday, 8 Aug 2017 08:57pm EDT

Aug 9 (Reuters) - Hawkins Inc -:Hawkins Inc reports first quarter fiscal 2018 results.Q1 earnings per share $0.55.Hawkins Inc - qtrly ‍sales $133.7 million versus $ 131.4 million.

Poland's Azoty says writedown to weigh on H1 results

Saturday, 5 Aug 2017 03:43am EDT

WARSAW, Aug 5 (Reuters) - Grupa Azoty ::Polish chemical group Azoty said on Friday that an asset value impairment at one of its subsidiaries will lower its operating profit by 14.7 million zlotys ($4.08 million) in the first half of 2017. .Azoty will publish a full financial report for the period on Aug. 24..

DSM H1 ‍net profit increases to 312 million​ euros

Tuesday, 1 Aug 2017 01:00am EDT

Aug 1 (Reuters) - KONINKLIJKE DSM NV ::H1 ‍NET PROFIT UP 42% TO EUR 312M​.‍INTERIM DIVIDEND OF EUR 0.58 PER ORDINARY SHARE​.‍OUTLOOK 2017: SLIGHTLY IMPROVED​.H1 ‍SALES UP 11% TO EUR 4,320M, WITH 8% ORGANIC GROWTH​.‍NOW EXPECTS TO DELIVER FULL-YEAR 2017 RESULTS ABOVE TARGETS SET OUT IN ITS STRATEGY 2018​.H1 ‍ADJUSTED EBITDA UP 16% TO EUR 721M​.SEES ‍EBITDA GROWTH FOR YEAR MOVING SLIGHTLY UP FROM HIGH SINGLE-DIGIT TO DOUBLE DIGIT​.FOR 2017 SEES ‍ROCE INCREASE MOVING FROM DOUBLE DIGIT BASIS POINTS TO OVER 100 BASIS POINTS​.

Sumitomo Dainippon Pharma U.S.-based unit enters agreement to divest asthma and allergy products to Covis pharma

Thursday, 13 Jul 2017 09:49pm EDT

July 14 (Reuters) - Sumitomo Dainippon Pharma Co Ltd <4506.T>:* Says its U.S.-based unit Sunovion Pharmaceuticals Inc. has.* The transaction is expected to close during the first half of Fiscal Year 2017, subject to customary closing conditions.

Zhejiang Jiangshan Chemical revises H1 net profit forecast

Sunday, 25 Jun 2017 10:17pm EDT

June 26 (Reuters) - Zhejiang Jiangshan Chemical Co Ltd <002061.SZ>:* Says it revises H1 forecast, expects H1 net profit to rise 1,027.97-1,153.31 percent to 180-200 million yuan ($26.32-29.24 million) .

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary